Pharmacist Management of Paxlovid eVisits
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,478
- 试验地点
- 2
- 主要终点
- Percent of patients with common potential drug-drug interactions with Paxlovid who received counseling
研究概览
简要总结
The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for common potential drug-drug interactions and time to prescription, as well as the time and financial costs of care in the two groups.
详细描述
Importance. Enhancing the management of messages from patients and providing virtual options for urgent care are top priorities for The Permanente Medical Group (TPMG) and Kaiser Foundation Hospitals/Health Plan (KFH/P).
Objective. To compare pharmacist management of e-visit requests for Paxlovid for COVID-19 with management by adult and family medicine physician pools regarding costs, time, clinical outcomes, and patient and clinician satisfaction.
Design, setting, and participants. This cluster randomized clinical trial will include adults from 17 medical facilities of Kaiser Permanente Northern California who make Paxlovid e-visits on weekdays from October 9 to December 11, 2023.
Intervention. In the intervention group, a regional team of pharmacists will manage Paxlovid e-visits following a standard protocol; in the comparison group, adult and family medicine physicians (AFMs) will manage these visits according to medical center-based protocols.
Main Outcomes and Measures. The primary outcome is whether a patient with one or more common drug-drug interactions received counseling for any drug-drug interaction. Secondary outcomes are the hours from the e-visit request to the prescription among patients who receive one and the clinician time and cost per visit managed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Outcomes Assessor)
盲法说明
Research assistants who review charts will be masked to patient group status.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients making Paxlovid e-visits on weekdays from 8:00 am to 4:30 pm during the study period
排除标准
- 未提供
结局指标
主要结局
Percent of patients with common potential drug-drug interactions with Paxlovid who received counseling
时间窗: Within 2 days after the e-visit
Whether or not a patient with one or more common potential drug-drug interactions with Paxlovid received counseling, as documented in the electronic health record, with data collected via review of text extracts from the EHR
次要结局
- Personnel cost per Paxlovid e-visit managed(Within 5 days after the e-visit)
- Mean hours from e-visit to Paxlovid prescription, among patients who received one(Within 2 days after the e-visit)
- Mean minutes of clinician time per Paxlovid e-visit managed(Within 2 days after the e-visit)